Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong
GlobeAlert Desk · curated from South China Morning Post · East Asia
Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals. The Li Ka Shing Foundation announced on Wednesday that CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would launch the trials using histotripsy, a technology that uses focused sound waves to break apart tumours without surgical incisions. The trials...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
What the desk knows about this story
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Single-source so far. Treat details as unconfirmed until more publishers report.
Not flagged as developing.
- The coral reef is too crowded shots prohibited between divers at 18 meters depth he tried to take my snorkel awayShootings · China · 1d ago
- Long March 12 | SatNet LEO Group TBD?Rocket Launches · CHN · now
- Long March 8A | SatNet LEO Group TBD?Rocket Launches · CHN · now